2. Inhibitory Antibodies
  3. Other

Other

Other

Other (10):

Cat. No. Product Name Purity Image
  • HY-P99974
    Nab-Paclitaxel 99.9%  
    Nab-Paclitaxel (Nanoparticle albumin-bound Paclitaxel) is an albumin-bound nanoparticle formulation of Paclitaxel (HY-B0015). Nab-Paclitaxel is composed of albumin and the active pharmaceutical ingredient Paclitaxel, in which human albumin is used as an excipient to disperse and stabilize particles and carry the main drug. Nab-Paclitaxel is a solvent-free taxane with higher response rates and improved tolerability. Nab-Paclitaxel displays less toxicity and greater antitumor activity. Nab-Paclitaxel is more readily available for tumor cell uptake in three rhabdomyosarcoma, seven neuroblastoma cell lines, and one ostersarcoma cell line Nab-Paclitaxel can be studied in cancer research for example breast cancer and solid tumors. (The product specifications below only indicate the effective content of Paditaxel, the actual albumin quality depends on the batch; the ratio of each ingredient in this product is Paditaxel: albumin -1:7~1:11).
    (2)
  • HY-P992098
    Adargiminase  
    Adargiminase (NEI-01) is a modified arginine-depleting enzyme and albumin binder. Adargiminase catalyzes the conversion of arginine to citrulline and ammonia, reduces plasma arginine levels to undetectable levels, and binds to serum albumin from Mus musculus (mouse), Rattus norvegicus (rat), Canis lupus familiaris (dog) and Homo sapiens (human) to extend its half-life. Adargiminase inhibits the viability of ASS1-negative pancreatic cancer cells, and reduces tumor volume and weight. Adargiminase can be used for the research of pancreatic cancer.
    Adargiminase
  • HY-P992087
    Insulin eflivet  
    Insulin eflivet is a recombinant antibody targeting insulin receptor. Insulin eflivet can be used in diabetes research.
    Insulin eflivet
  • HY-P992152
    Vatreptacog alfa  
    Vatreptacog alfa is a recombinant hFVIIa analog, differing from native FVIIa by three amino acid substitutions (V158D, E296V and M298Q) in the protease domain. Vatreptacog alfa exhibits enhanced tissue factor-independent enzymatic activity toward activated platelets. Vatreptacog alfa can be used in the research of hemophilia.
    Vatreptacog alfa
  • HY-P992154
    Ricefidase  
    Ricefidase (KJ-103) is a recombinant human immunoglobulin G-degrading enzyme. Ricefidase efficiently cleaves human IgG at the hinge region. Ricefidase rapidly reduces IgG levels. Ricefidase has low immunogenicity and clears AAV neutralizing antibodies. Ricefidase is applicable to research related to desensitization of all IgG subclasses and improvement of the suitability of AAV-based gene therapy.
    Ricefidase
  • HY-P992149
    Lutropin alfa  
    Lutropin alfa is a recombinant human luteinizing hormone (LH). Lutropin alfa consists of non-covalently linked α and β subunits, and its activity is similar to that of natural luteinizing hormone. Lutropin alfa is used to stimulate follicular development in infertility.
    Lutropin alfa
  • HY-P992106
    Dazupegleukin  
    Dazupegleukin is an interleukin-2 derivative with antineoplastic properties.
    Dazupegleukin
  • HY-P992119
    Loncipoetin alfa  
    Loncipoetin alfa is a mutant of human erythropoietin, which can be used in the research of anemia.
    Loncipoetin alfa
  • HY-P992147
    Zinihyaluronidase alfa  
    Zinihyaluronidase alfa is a hyaluronidase.
    Zinihyaluronidase alfa
  • HY-119810A
    Seletracetam lithium  
    Seletracetam (Ucb 44212) lithium, as an analog of the antiepileptic agent Levetiracetam, is a SV2A modulator for the research of epilepsy.
    Seletracetam lithium